oral drug delivery

showdown clash versus vs crash lightning fight dispute
Pharma

The Oral GLP-1 Tracker: Wegovy pill numbers show its appeal

Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
Novo Nordisk

Novo's Wegovy pill debuts with $355M in Q1

May 6, 2026 11:21am
Eli Lilly Lilly

Lilly stands behind strength of early Foundayo launch

Apr 30, 2026 11:42am
Novo Nordisk

Novo eyes adolescent diabetes approval for oral semaglutide

Apr 23, 2026 11:03am
Eli Lilly Lilly

Lilly answers FDA's call for more Foundayo safety information

Apr 16, 2026 9:43am
launch button

Analysts pin high hopes early on Lilly's Foundayo launch

Apr 2, 2026 11:42am